Literature DB >> 12663729

Improving the care of patients with regard to chemotherapy-induced nausea and emesis: the effect of feedback to clinicians on adherence to antiemetic prescribing guidelines.

Wilson C Mertens1, Donald J Higby, David Brown, Regina Parisi, Janice Fitzgerald, Evan M Benjamin, Peter K Lindenauer.   

Abstract

PURPOSE: To evaluate the effect of performance and outcomes feedback on adherence to clinical practice guidelines regarding chemotherapy-induced nausea and emesis (CINE).
METHODS: Institutional CINE clinical practice guidelines were developed based on American Society of Clinical Oncology guidelines. Consecutive administrations of moderately/highly emetogenic chemotherapy were assessed for errors. Baseline statistical process control (SPC) charts were created and mean errors per administration were calculated. Prospective SPC charts were used to measure the effect of guideline development and distribution, a visiting lecturer, and ongoing feedback regarding compliance with guidelines employing SPC charts. Patients were surveyed regarding the extent and severity of CINE for 5 days postadministration. These outcomes were then shared with physicians.
RESULTS: Baseline compliance was poor (mean, 0.87 omissions per chemotherapy administration), largely because of inadequate adherence to recommendations for delayed CINE management. Most patients experienced delayed nausea, particularly on day 3 postchemotherapy. Physician prescribing performance did not undergo sustained improvement despite guideline development or distribution, a lecture by a visiting expert, or sharing of adherence data with clinicians. Once patient outcomes were shared, physicians accepted the need for compliance and instituted nurse practitioner antiemetic prescribing, with almost complete compliance and concurrent measurable reduction in day 3 nausea. SPC charts documented improvements in both outcomes.
CONCLUSIONS: SPC charts effectively monitor ongoing compliance and patient symptoms and represent appropriate outcome measurement and change facilitation tools. However, physician participation in guideline development and evidence of poor compliance alone did not improve prescribing performance. Only evidence of patient CINE experience coupled with noncompliance improved results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663729     DOI: 10.1200/JCO.2003.08.118

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  23 in total

1.  The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries.

Authors:  Snezana Bosnjak
Journal:  Support Care Cancer       Date:  2003-10-15       Impact factor: 3.603

2.  Antiemetic prescribing practices using a computerized physician order entry system.

Authors:  Kunal C Kadakia; Alexis D Leal; Drew K Seisler; Rui Qin; Kelliann C Fee-Schroeder; Darryl C Grendahl; Kristine M Sorgatz; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2013-09-13       Impact factor: 3.603

Review 3.  Application of statistical process control in healthcare improvement: systematic review.

Authors:  Johan Thor; Jonas Lundberg; Jakob Ask; Jesper Olsson; Cheryl Carli; Karin Pukk Härenstam; Mats Brommels
Journal:  Qual Saf Health Care       Date:  2007-10

Review 4.  ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.

Authors:  Yasmeen Razvi; Stephanie Chan; Thomas McFarlane; Erin McKenzie; Pearl Zaki; Carlo DeAngelis; William Pidduck; Ahmad Bushehri; Edward Chow; Katarzyna Joanna Jerzak
Journal:  Support Care Cancer       Date:  2018-10-03       Impact factor: 3.603

5.  Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study.

Authors:  Michelino De Laurentiis; Chiara Bonfadini; Vito Lorusso; Giuseppina Cilenti; Francesca Di Rella; Giuseppe Altavilla; Manuela Otero; Antonio Ardizzoia; Paolo Marchetti; Giorgia Peverelli; Domenico Amoroso; Stefania Vecchio; Elena Fiorio; Simona Orecchia
Journal:  Support Care Cancer       Date:  2018-06-25       Impact factor: 3.603

6.  Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting.

Authors:  Henning Burmeister; Stefan Aebi; Cristina Studer; Martin F Fey; Oliver Gautschi
Journal:  Support Care Cancer       Date:  2011-01-14       Impact factor: 3.603

7.  The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation.

Authors:  Richard Benoit Francoeur
Journal:  J Pain Symptom Manage       Date:  2005-02       Impact factor: 3.612

8.  Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data.

Authors:  Matti Aapro; Florian Scotté; Yolanda Escobar; Luigi Celio; Richard Berman; Alessandra Franceschetti; Danielle Bell; Karin Jordan
Journal:  Oncologist       Date:  2021-03-17

9.  Chemotherapy-Induced Nausea and Vomiting Prophylaxis: Practice Within the Children's Oncology Group.

Authors:  Priya Patel; Paula D Robinson; Andrea Orsey; Jason L Freedman; Anne-Marie Langevin; Debbie Woods; Lillian Sung; L Lee Dupuis
Journal:  Pediatr Blood Cancer       Date:  2016-01-27       Impact factor: 3.167

10.  Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice.

Authors:  Mary Lou Affronti; Susan M Schneider; James E Herndon; Susan Schlundt; Henry S Friedman
Journal:  Support Care Cancer       Date:  2014-02-26       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.